The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Listeria monocytogenes infections linked to ready-to-eat (RTE) foods produced by Fresh & Ready Foods LLC of San Fernando, California.

FDA and CDC began investigating this cluster in 2024. However, there was not enough evidence in the previous investigation to identify a source for the outbreak. The investigation was reopened in April 2025 after FDA investigators found Listeria in environmental samples collected from Fresh & Ready Foods LLC during a routine surveillance inspection. Whole genome sequencing (WGS) analysis confirmed that the strain of Listeria found at Fresh & Ready Foods LLC matches the strain of Listeria causing illnesses in this outbreak.

Additionally, based on epidemiological information provided by CDC, state, and local public health officials interviewed people about the foods they ate before they got sick. Of the six people for whom information is available, all six (100 percent) were hospitalized and later became sick with Listeria. Records reviewed from facilities indicated that ready-to-eat foods made by Fresh & Ready Foods LLC were confirmed to have been served in at least three of these facilities. As of May 9, 2025, a total of 10 people infected with the outbreak strain of Listeria monocytogenes have been reported from two states. All 10 people have been hospitalized.

In response to this investigation, Fresh & Ready Foods LLC voluntarily recalled several of its RTE foods, including sandwiches and snack items. The recalled products are identified by the “Use By” dates from 4/22/2025 to 05/19/2025 and include the following brand names:

• Fresh & Ready Foods
• City Point Market Fresh Food to Go
• Fresh Take Crave Away

The recalled products were distributed between April 18, 2025, and April 28, 2025, and sold in Arizona, California, Nevada, and Washington at a variety of locations, including retailers and foodservice locations such as hospitals, hotels, convenience stores, airports, and airlines.

FDA’s investigation is ongoing, and more information will be provided as it becomes available.